{"title":"代谢性脂肪变性:最近的科学数据也支持命名法的改变。","authors":"N Lanthier, M J Armstrong","doi":"10.51821/86.1.11385","DOIUrl":null,"url":null,"abstract":"Two years ago, many experts spoke out in favour of changing the nomenclature of the most common liver disease in the world, non-alcoholic fatty liver disease (NAFLD) (1). This was the subject of an editorial in the Acta Gastroenterologica Belgica Journal (1). Even though many researchers still mention that its pathophysiology remains poorly understood or that the exact mechanisms remain to be elucidated, it would be dishonest not to recognise a common factor, namely the metabolic context (metabolic syndrome, insulin resistance and possibly type 2 diabetes, overweight or obesity) in the pathogenesis of this liver disease (1). The term “MAFLD” for “metabolic dysfunction-associated fatty liver disease” therefore makes sense. It is indeed more logical to call something by what it is than by what it is not (1). The perceived stigma of patients using the term “alcoholic” in naming their disease also supports an adaptation of the nomenclature (2).","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Metabolic steatosis: recent scientific data also support a change in nomenclature.\",\"authors\":\"N Lanthier, M J Armstrong\",\"doi\":\"10.51821/86.1.11385\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Two years ago, many experts spoke out in favour of changing the nomenclature of the most common liver disease in the world, non-alcoholic fatty liver disease (NAFLD) (1). This was the subject of an editorial in the Acta Gastroenterologica Belgica Journal (1). Even though many researchers still mention that its pathophysiology remains poorly understood or that the exact mechanisms remain to be elucidated, it would be dishonest not to recognise a common factor, namely the metabolic context (metabolic syndrome, insulin resistance and possibly type 2 diabetes, overweight or obesity) in the pathogenesis of this liver disease (1). The term “MAFLD” for “metabolic dysfunction-associated fatty liver disease” therefore makes sense. It is indeed more logical to call something by what it is than by what it is not (1). The perceived stigma of patients using the term “alcoholic” in naming their disease also supports an adaptation of the nomenclature (2).\",\"PeriodicalId\":7322,\"journal\":{\"name\":\"Acta gastro-enterologica Belgica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta gastro-enterologica Belgica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.51821/86.1.11385\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta gastro-enterologica Belgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.51821/86.1.11385","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Metabolic steatosis: recent scientific data also support a change in nomenclature.
Two years ago, many experts spoke out in favour of changing the nomenclature of the most common liver disease in the world, non-alcoholic fatty liver disease (NAFLD) (1). This was the subject of an editorial in the Acta Gastroenterologica Belgica Journal (1). Even though many researchers still mention that its pathophysiology remains poorly understood or that the exact mechanisms remain to be elucidated, it would be dishonest not to recognise a common factor, namely the metabolic context (metabolic syndrome, insulin resistance and possibly type 2 diabetes, overweight or obesity) in the pathogenesis of this liver disease (1). The term “MAFLD” for “metabolic dysfunction-associated fatty liver disease” therefore makes sense. It is indeed more logical to call something by what it is than by what it is not (1). The perceived stigma of patients using the term “alcoholic” in naming their disease also supports an adaptation of the nomenclature (2).
期刊介绍:
The Journal Acta Gastro-Enterologica Belgica principally publishes peer-reviewed original manuscripts, reviews, letters to editors, book reviews and guidelines in the field of clinical Gastroenterology and Hepatology, including digestive oncology, digestive pathology, as well as nutrition. Pure animal or in vitro work will not be considered for publication in the Journal. Translational research papers (including sections of animal or in vitro work) are considered by the Journal if they have a clear relationship to or relevance for clinical hepato-gastroenterology (screening, disease mechanisms and/or new therapies). Case reports and clinical images will be accepted if they represent an important contribution to the description, the pathogenesis or the treatment of a specific gastroenterology or liver problem. The language of the Journal is English. Papers from any country will be considered for publication. Manuscripts submitted to the Journal should not have been published previously (in English or any other language), nor should they be under consideration for publication elsewhere. Unsolicited papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision. Manuscripts that do not meet the presentation criteria (as indicated below) will be returned to the authors. Papers that go too far beyond the scope of the journal will be also returned to the authors by the editorial board generally within 2 weeks. The Journal reserves the right to edit the language of papers accepted for publication for clarity and correctness, and to make formal changes to ensure compliance with AGEB’s style. Authors have the opportunity to review such changes in the proofs.